BP p.l.c. (NYSE:BP) is investigating whether in-house financial traders at the oil and gas group were involved in a foreign exchange manipulation scandal that has led regulators to levy $4.3bn in fines on six banks.On last trading day BP p.l.c. (NYSE:BP) fell -0.63% to close at $38.12. Its volatility for the week is 1.08% while volatility for the month is 2.21%. BP’s sales growth for past 5 years was 1.00% and its EPS growth for past 5 years was 2.00%. BP p.l.c. (NYSE:BP) monthly performance is -4.29%.
Rand Logistics (NASDAQ:RLOG) CEO Edward Levy acquired 10,600 shares of the company’s stock on the open market in a transaction dated Wednesday, December 3rd. The stock was purchased at an average cost of $4.30 per share, for a total transaction of $45,580.00. Rand Logistics, Inc. (NASDAQ:RLOG) has 7.30% insider ownership while its institutional ownership stands at 75.70%. In last trading activity company’s stock closed at $3.95.
Research analysts at Barclays cut their price objective on shares of Calumet Specialty Products Partners, L.P (NASDAQ:CLMT) from $32.00 to $26.00 in a report released on Friday. The firm currently has an “equal weight” rating on the stock. On Wednesday shares of Calumet Specialty Products Partners LP (NASDAQ:CLMT) closed at $22.41. Company’s sales growth for last 5 years was 16.80% and EPS growth for next 5 years is recorded as 11.60%.
United Therapeutics Corp. (NASDAQ:UTHR) said it has signed an agreement with DEKA Research & Development Corp. for the development of a potential technology breakthrough in the subcutaneous delivery of Remodulin or treprostinil Injection to patients with pulmonary arterial hypertension via a pre-filled semi-disposable pump system. Financial terms of the agreement were not announced. United Therapeutics Corporation (NASDAQ:UTHR) in last trading activity moved down -1.00% to close at $129.49. Company weekly performance is 1.31% while its quarterly performance stands at -0.73%. United Therapeutics Corporation (NASDAQ:UTHR) is -6.06% away from its 52 week high.
According to Thomson Reuters, 13 Wall Street analysts rate the supercharged electric car Tesla Motors Inc (NASDAQ:TSLA) stock a “buy” or a “strong buy,” compared with just one lonely individual prepared to rate it an “underperform.” None dare call it a “sell.” Bold talk for a stock that’s gone from $37 to $223 in less than two years, and is today trading at a lofty seven times forecast annual revenue…and more than 360 times forecast “pre-exceptional” per-share earnings On last trading day Tesla Motors Inc (NASDAQ:TSLA) increased 0.08% to close at $222.41. Its volatility for the week is 1.97% while volatility for the month is 3.28%. TSLA’s sales growth for past 5 years was 167.50% and its EPS growth for past 5 years was 45.10%. Tesla Motors Inc (NASDAQ:TSLA) monthly performance is -3.98%.